• Privacy policy
  • T&C’s
  • About Us
    • FAQ
    • Meet the Team
  • Contact us
  • Guest Content
TLE ONLINE SHOP!
  • TLE
  • News
  • Politics
  • Business
  • Sport
  • Opinion
  • Elevenses
  • Entertainment
    • All Entertainment
    • Film
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
  • Food
    • All Food
    • Recipes
  • Property
  • Travel
  • Tech/Auto
  • JOBS
No Result
View All Result
The London Economic
SUPPORT THE LONDON ECONOMIC
NEWSLETTER
  • TLE
  • News
  • Politics
  • Business
  • Sport
  • Opinion
  • Elevenses
  • Entertainment
    • All Entertainment
    • Film
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
  • Food
    • All Food
    • Recipes
  • Property
  • Travel
  • Tech/Auto
  • JOBS
No Result
View All Result
The London Economic
No Result
View All Result
Home Business and Economics Business

PhD boffin set to be one of richest men in Britain after his company is sold for £625million

Harry Destecroix, 31, set up Ziylo while studying for his doctorate - and the firm could revolutionise the treatment of diabetes

Joe Mellor by Joe Mellor
2018-08-21 11:14
in Business, News
FacebookTwitterLinkedinEmailWhatsapp

Brainy Harry Destecroix, 31, set up Ziylo while studying for his doctorate – and the firm could revolutionise the treatment of diabetes.

The PhD scientist and other shareholders could become some of the richest men in Britain after his company started at university was sold – for around £625 MILLION.

Novo Nordisk, the world’s biggest maker of diabetes drugs, has agreed to buy Ziylo to develop new forms of insulin.

Total payments under the agreement could ultimately exceed $800m (£624m) upon the achievement of development, regulatory and sales milestones by Novo Nordisk.

Ziylo has developed synthetic molecules which bind to glucose in the bloodstream to help diabetics control their condition.

It eliminates the risk of low blood sugar which can lead to death in severest cases.

Scientists at the university’s Davis Research Group, including professor Anthony Davis, worked on the problem for many years before Ziylo was established in 2014.

The firm was spun out of the University of Bristol, where Destecroix earned his doctorate in chemistry four years ago.

RelatedPosts

More private jets left UK than any other European country in 2022

Around £21bn lost to fraud since start of pandemic, says watchdog

Mhairi Black shreds Raab after Led By Donkeys sting

Local Tories issue legal threats over plans for asylum seekers

Harry Destecroix  around the time co-founded Ziylo with Prof Anthony Davis, of the University of Bristol and Tom Smart.

The glucose-binding molecules were designed by Bristol professor Anthony Davis.

Dr Harry Destecroix said: “Novo Nordisk, as the leader in the diabetes field, is the ideal company to maximise the potential of the Ziylo’s glucose binding molecules in glucose responsive insulins and diabetes applications, and it brings hope of a truly ground-breaking treatment to diabetes patients.”

Anthony Davis, Professor of Supramolecular Chemistry at the University of Bristol and Director & Co-Founder of Ziylo, added: “The glucose responsive insulin we will develop with Novo Nordisk combines a natural molecule (insulin) with an artificial component (Ziylo’s glucose binding molecules). This combination of natural and unnatural could be a new approach to biodesign.”

Ziylo has received just £2m in funding since its formation, from individual angel investors and government grants.

Mr Destecroix said Novo Nordisk could start clinical trials of products based on Ziylo technology within three years.

The research and development work will take place in Novo Nordisk’s new £115m diabetes research centre in Oxford, which will be inaugurated next month, as well as at its facilities in Denmark.

Professor Nishan Canagarajah, Pro Vice-Chancellor for Research at the University of Bristol, said: “The university is proud of its cutting-edge research which has potential to generate major societal impact. It is gratifying to see our research being developed to the point where it has the potential to make a real difference to people’s lives.

“The acquisition of Ziylo by Novo Nordisk will allow this technology to take the next leap forward – well done to the team at Ziylo and to Professor Davis and his team at the University for getting to this exciting point.”

Content Protection by DMCA.com

Since you are here

Since you are here, we wanted to ask for your help.

Journalism in Britain is under threat. The government is becoming increasingly authoritarian and our media is run by a handful of billionaires, most of whom reside overseas and all of them have strong political allegiances and financial motivations.

Our mission is to hold the powerful to account. It is vital that free media is allowed to exist to expose hypocrisy, corruption, wrongdoing and abuse of power. But we can't do it without you.

If you can afford to contribute a small donation to the site it will help us to continue our work in the best interests of the public. We only ask you to donate what you can afford, with an option to cancel your subscription at any point.

To donate or subscribe to The London Economic, click here.

The TLE shop is also now open, with all profits going to supporting our work.

The shop can be found here.

You can also SUBSCRIBE TO OUR NEWSLETTER .

Subscribe to our Newsletter

View our  Privacy Policy and Terms & Conditions

Trending on TLE

  • All
  • trending

Elevenses: Exposing the Tories’ Deepfake Illegal Immigration Bill

Elevenses: Rishi’s Finest Hour

Elevenses: Fear and Loathing in the New Conservatives

More from TLE

PMQs 22nd March – The upper classes educating the masses

The Beatles – Sgt. Pepper’s Lonely Hearts Club Band 50th Anniversary Edition Announced

US Supreme Court allows use of Pentagon funds for border wall

Escape to the country: Best Places to live 2021

Shopworker describes harrowing moment she heard London’s latest knife crime victim utter “his last words”

Iguana-sized reptile – an early relative of crocodiles and dinosaurs – found in Antarctica

Boy, 15, repeatedly stabbed in south London

Climate change causes hurricanes to linger causing more devastation than ever

Majority of Labour members still believe Jeremy Corbyn is the right man for the job

Horrifying photos show seals now under constant threat from plastic rubbish

JOBS

FIND MORE JOBS

About Us

TheLondonEconomic.com – Open, accessible and accountable news, sport, culture and lifestyle.

Read more

Contact

Editorial enquiries, please contact: [email protected]

Commercial enquiries, please contact: [email protected]

Address

The London Economic Newspaper Limited t/a TLE
Company number 09221879
International House,
24 Holborn Viaduct,
London EC1A 2BN,
United Kingdom

SUPPORT

We do not charge or put articles behind a paywall. If you can, please show your appreciation for our free content by donating whatever you think is fair to help keep TLE growing and support real, independent, investigative journalism.

DONATE & SUPPORT

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.




No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • JOBS
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Meet the Team
    • Privacy policy
  • Contact us

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.